Hong Wu

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0003-4789-8535

发表论文 23 篇 · 总被引 811 次 · h-index 9

代表论文

• TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of β-catenin (2019 · Cell Death and Differentiation · 被引 180)
• Phase 1 clinical trial demonstrated that MUC1 positive metastatic seminal vesicle cancer can be effectively eradicated by modified Anti-MUC1 chimeric antigen receptor transduced T cells (2016 · Science China Life Sciences · 被引 153)
• Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma (2010 · Molecular Cancer · 被引 134)
• MicroRNAs Associated With HBV Infection And HBV-related HCC (2014 · Theranostics · 被引 116)
• TAZ is indispensable for c-MYC-induced hepatocarcinogenesis (2021 · Journal of Hepatology · 被引 96)
• Expression of microRNA-150 targeting vascular endothelial growth factor-A is downregulated under hypoxia during liver regeneration (2013 · Molecular Medicine Reports · 被引 48)